201 related articles for article (PubMed ID: 34127075)
1. Differential effects of risk factors on the cognitive trajectory of early- and late-onset Alzheimer's disease.
Kim J; Woo SY; Kim S; Jang H; Kim J; Kim J; Kang SH; Na DL; Chin J; Apostolova LG; Seo SW; Kim HJ
Alzheimers Res Ther; 2021 Jun; 13(1):113. PubMed ID: 34127075
[TBL] [Abstract][Full Text] [Related]
2. APOE ε4 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer's disease.
Polsinelli AJ; Logan PE; Lane KA; Manchella MK; Nemes S; Sanjay AB; Gao S; Apostolova LG
Alzheimers Dement; 2023 May; 19(5):1983-1993. PubMed ID: 36394443
[TBL] [Abstract][Full Text] [Related]
3. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
Wattmo C; Wallin ÅK
Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
[TBL] [Abstract][Full Text] [Related]
4. Age-at-Onset and
Smirnov DS; Galasko D; Hiniker A; Edland SD; Salmon DP
Neurology; 2021 May; 96(18):e2272-e2283. PubMed ID: 33722993
[TBL] [Abstract][Full Text] [Related]
5. Early-onset Alzheimer's disease shows a distinct neuropsychological profile and more aggressive trajectories of cognitive decline than late-onset.
Tort-Merino A; Falgàs N; Allen IE; Balasa M; Olives J; Contador J; Castellví M; Juncà-Parella J; Guillén N; Borrego-Écija S; Bosch B; Fernández-Villullas G; Ramos-Campoy O; Antonell A; Rami L; Sánchez-Valle R; Lladó A
Ann Clin Transl Neurol; 2022 Dec; 9(12):1962-1973. PubMed ID: 36398437
[TBL] [Abstract][Full Text] [Related]
6. APOE ε4 is associated with earlier symptom onset in LOAD but later symptom onset in EOAD.
Polsinelli AJ; Lane KA; Manchella MK; Logan PE; Gao S; Apostolova LG
Alzheimers Dement; 2023 May; 19(5):2212-2217. PubMed ID: 36722399
[TBL] [Abstract][Full Text] [Related]
7. Cognitive profiles and neuropsychiatric symptoms in Korean early-onset Alzheimer's disease patients: a CREDOS study.
Park HK; Choi SH; Park SA; Kim HJ; Lee Y; Han SH; Kim EJ; Kim BC; Han HJ; Moon SY; Yang DW; Park KW; Park KH; Yoon B; Seo SW; Na DL; Na HR; Lee JH
J Alzheimers Dis; 2015; 44(2):661-73. PubMed ID: 25322926
[TBL] [Abstract][Full Text] [Related]
8. The APOE4 effect: structural brain differences in Alzheimer's disease according to the age at symptom onset.
Forno G; Contador J; Pérez-Millan A; Guillen N; Falgàs N; Sarto J; Tort-Merino A; Castellví M; Bosch B; Fernández-Villullas G; Balasa M; Antonell A; Sala-Llonch R; Sanchez-Valle R; Hornberger M; Lladó A
Eur J Neurol; 2023 Mar; 30(3):597-605. PubMed ID: 36463489
[TBL] [Abstract][Full Text] [Related]
9. Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD.
Mendez MF
Arch Med Res; 2012 Nov; 43(8):677-85. PubMed ID: 23178565
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E genotype in sporadic early- and late-onset Alzheimer's disease.
Masullo C; Daniele A; Seripa D; Filippini V; Gravina C; Carbone G; Gainotti G; Fazio VM
Dement Geriatr Cogn Disord; 1998; 9(3):121-5. PubMed ID: 9621997
[TBL] [Abstract][Full Text] [Related]
11. Early-onset and late-onset Alzheimer's disease are associated with distinct patterns of memory impairment.
Joubert S; Gour N; Guedj E; Didic M; Guériot C; Koric L; Ranjeva JP; Felician O; Guye M; Ceccaldi M
Cortex; 2016 Jan; 74():217-32. PubMed ID: 26694580
[TBL] [Abstract][Full Text] [Related]
12. Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer's disease.
Eur J Nucl Med Mol Imaging; ; . PubMed ID: 34997294
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
